CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy

CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Opis bibliograficzny
1. autor:	Eva, Israt Ara Jannat
Kolejni autorzy:	Rahman, Kazi Fatema
Format:	Praca dyplomowa
Język:	English
Wydane:	Brac University 2023
Hasła przedmiotowe:	CRISPR/Cas9 mechanism In vivo and in vitro modeling CRISPR/Cas9 delivery Mutation targeting in cancer and DMD Chromosomal rearrangement Mouse modeling Off-target limitation DMD mutation in human iPSCs Myoediting of DMD Therapeutic application of CRISPR Molecular genetics Cancer > Treatment
Dostęp online:	http://hdl.handle.net/10361/17764

Podobne zapisy

A review on CRISPR-Cas system based applications in Oncology
od: Sadia, Mir
Wydane: (2022)

CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
od: Maria, Amatul
Wydane: (2020)

Comparative analysis of CRISPR-Cas systems of Yersinia pestis and Escherichia coli strains. (November 2020 – December 2021)
od: Nwabunwanne, Eze Uchenna
Wydane: (2022)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
od: Shaikat, Mahdi Mubin
Wydane: (2023)

CRISPR/Cas9 genome editing to treat sickle cell disease
od: Ullah, Mohammad
Wydane: (2023)

A review on CRISPR Technology as an Antiviral Tool
od: Srishti, Sanjida Ahmed
Wydane: (2023)

A review paper on Nanotechnology based strategies in the treatment of cancer
od: Rahman, Samia
Wydane: (2022)

Biased acquisition of spacers by the CRISPR System of the V. cholerae
od: Supan, Erena Tuzneen, i wsp.
Wydane: (2021)

Analysis and comparison between the Genome of CRISPR bacteriophages
od: Muntaha, Mumtasin
Wydane: (2021)

Distribution of complete CRISPR-Cas systems in vibrio cholerae and its effect on presence of plasmid derived contigs in complete genome assemblies
od: Reza, Ratul
Wydane: (2024)

Trend in approval of targeted biologics in the last two decades
od: Siddika, Khadiza
Wydane: (2024)

Exploring the possible function and acquisition pattern of self-targeting Spacers: in five common infectious bacteria
od: Kenneth, Mutebi John
Wydane: (2019)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
od: Bristy, Israt Zerin
Wydane: (2021)

A comprehensive in silico investigation into the pathogenic SNPs in RTEL1 gene and their biological consequences
od: Tanshee, Rifah Rownak
Wydane: (2023)

The microbial models of molecular biology
od: Davis, Rowland H.

SIRT6 and cancer stem cells: is there any implication?
od: Sarker, Tanosi
Wydane: (2022)

Assessing the interspecies and intraspecies diversity of Cas1 and Cas3 proteins of the CRISPR-Cas system in vibrio cholera and Escherichia coli strains
od: Tabassum, Tahani, i wsp.
Wydane: (2022)

Genetic disorders associated with mutations in bHLH transcription factors: a review
od: Joya, Mollika Bharadwaj
Wydane: (2023)

Exploring of deletion mutation causative for Duchenne Muscular Dystrophy (DMD) in Bangladesh cohort
od: Eshaque, Tamannyat Binte
Wydane: (2024)

A review on targeted therapies for lung cancer
od: Ashraf, Anushey
Wydane: (2023)

Molecules associated with the development of lung cancer
od: Rahman, Adree, i wsp.
Wydane: (2023)

Inside the human genome
od: Avise, John C.

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
od: Nahar, Kamrun
Wydane: (2023)

State of Thalassemia in Bangladesh: a review
od: Reedoy, Md. Shariqul Islam
Wydane: (2022)

Carcinogenesis

Molecular biology of cancer : mechanisms, targets, and therapeutics /
od: Pecorino, Lauren
Wydane: (2012)

Molecular biology of the gene /
Wydane: (2004)

Introduction to genetic analysis /
Wydane: (2012)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
od: Meem, Manila
Wydane: (2023)

iGenetics : a molecular approach /
od: Russell, Peter J.
Wydane: (2006)

iGenetics : a molecular approach /
od: Russell, Peter J.
Wydane: (2010)

Modern genetic analysis : integrating genes and genomes /
od: Griffiths, Anthony J. F.
Wydane: (2002)

Targeted therapeutic options in the treatment of Breast Cancer
od: Alam, Kazi Tasnuva
Wydane: (2022)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
od: Paul, Pulock
Wydane: (2024)

The current cancer situation in metropolitan Dhaka
od: Morshid, Golam
Wydane: (2023)

Molecular biology and biotechnology : a guide for teachers /
od: Kreuzer, Helen
Wydane: (2008)

Banking credit for farm inputs marketing business : macro perspective and micro realities / Bhupat M. Desai, N.V. Namboodiri.
od: Desai, B. M. 1938
Wydane: (1996)

Repurposing Albendazole and Mebendazole, an antiparasitic drug in treating colorectal cancer- a review
od: Mondal, Shawon
Wydane: (2023)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
od: Karim, Azrin
Wydane: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
od: Tania, Umme
Wydane: (2023)